Chemoinformaics analysis of 4-Allylphenyl acetate
| Molecular Weight | 176.215 | nRot | 3 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 14 |
| Exact Molecular Weight | 176.084 | nRing | 1 |
| Solubility: LogS | -4.333 | nHRing | 0 |
| Solubility: LogP | 3.838 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 27.9755 |
| nHD | 0 | BPOL | 14.6425 |
| QED | 0.617 |
| Synth | 4.721 |
| Natural Product Likeliness | 3.425 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.585 |
| MDCK | 0.000017 |
| BBB | 0.977 |
| PPB | 0.60912 |
| VDSS | 1.186 |
| FU | 0.460747 |
| CYP1A2-inh | 0.081 |
| CYP1A2-sub | 0.306 |
| CYP2c19-inh | 0.057 |
| CYP2c19-sub | 0.832 |
| CYP2c9-inh | 0.057 |
| CYP2c9-sub | 0.544 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.78 |
| CYP3a4-inh | 0.021 |
| CYP3a4-sub | 0.341 |
| CL | 11.806 |
| T12 | 0.096 |
| hERG | 0.013 |
| Ames | 0.03 |
| ROA | 0.061 |
| SkinSen | 0.046 |
| Carcinogencity | 0.756 |
| EI | 0.299 |
| Respiratory | 0.097 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.753407 |